Login to Your Account

IMI 2 to Launch in January; $4.5B for Vaccines, Drugs

By Nuala Moran
Staff Writer

Wednesday, July 17, 2013
LONDON – The European Union said the second phase of the Innovative Medicines Initiative (IMI 2) will get under way in January 2014 with a budget of €3.45 billion (US$4.5 billion) to be devoted to the development of vaccines and treatments for a range of chronic and degenerative diseases.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription